{"id":"https://openalex.org/W3119217366","doi":"https://doi.org/10.1177/1078155220981155","title":"Delayed immune thrombocytopenia after discontinuation of nivolumab therapy: A case report and literature review","display_name":"Delayed immune thrombocytopenia after discontinuation of nivolumab therapy: A case report and literature review","publication_year":2021,"publication_date":"2021-01-12","ids":{"openalex":"https://openalex.org/W3119217366","doi":"https://doi.org/10.1177/1078155220981155","mag":"3119217366","pmid":"https://pubmed.ncbi.nlm.nih.gov/33435825"},"language":"en","primary_location":{"id":"doi:10.1177/1078155220981155","doi":"https://doi.org/10.1177/1078155220981155","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1078155220981155","pdf_url":null,"source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040328245","display_name":"Shengya Fu","orcid":"https://orcid.org/0000-0002-3203-0699","observed_orcids":["https://orcid.org/0000-0002-3203-0699"]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shengya Fu","raw_affiliation_strings":["Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China"],"raw_orcid":"https://orcid.org/0000-0002-3203-0699","affiliations":[{"raw_affiliation_string":"Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China","institution_ids":["https://openalex.org/I24185976"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100428022","display_name":"Ting Wang","orcid":"https://orcid.org/0000-0003-4654-5869","observed_orcids":["https://orcid.org/0000-0003-4654-5869"]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ting Wang","raw_affiliation_strings":["Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China","institution_ids":["https://openalex.org/I24185976"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100616022","display_name":"Feng Xu","orcid":"https://orcid.org/0000-0003-0902-2858","observed_orcids":["https://orcid.org/0000-0003-0902-2858"]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Feng Xu","raw_affiliation_strings":["Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China","institution_ids":["https://openalex.org/I24185976"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5100616022"],"corresponding_institution_ids":["https://openalex.org/I24185976"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.8003,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.72086687,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"27","issue":"6","first_page":"1548","last_page":"1552"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.008500000461935997,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-thrombocytopenic-purpura","display_name":"idiopathic thrombocytopenic purpura","score":0.9639999866485596},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8870000243186951},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.824999988079071},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.8510000109672546},{"id":"https://openalex.org/keywords/metastatic-nsclc","display_name":"metastatic non-small cell lung cancer","score":0.9919999837875366},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.753000020980835},{"id":"https://openalex.org/keywords/corticosteroid-therapy","display_name":"corticosteroid therapy","score":0.7960000038146973},{"id":"https://openalex.org/keywords/eltrombopag","display_name":"eltrombopag","score":0.9890000224113464},{"id":"https://openalex.org/keywords/platelet-transfusion","display_name":"platelet transfusion","score":0.8360000252723694},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.49900001287460327}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9192874431610107},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.9132215976715088},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.7615007162094116},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6991617679595947},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5188280940055847},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4786168932914734},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4654320776462555},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38794007897377014},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3519098460674286}],"mesh":[{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013921","descriptor_name":"Thrombocytopenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D016553","descriptor_name":"Purpura, Thrombocytopenic, Idiopathic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/1078155220981155","doi":"https://doi.org/10.1177/1078155220981155","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1078155220981155","pdf_url":null,"source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},{"id":"pmid:33435825","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33435825","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1605630196","https://openalex.org/W1991437102","https://openalex.org/W2010121426","https://openalex.org/W2016292939","https://openalex.org/W2067978628","https://openalex.org/W2166662937","https://openalex.org/W2580311324","https://openalex.org/W2760421385","https://openalex.org/W2780791607","https://openalex.org/W2786816161","https://openalex.org/W2790743957","https://openalex.org/W2793179089","https://openalex.org/W2795668706","https://openalex.org/W2885776529","https://openalex.org/W2902242842","https://openalex.org/W2902822641","https://openalex.org/W2925446385","https://openalex.org/W2948841882","https://openalex.org/W2956028371","https://openalex.org/W2982278711","https://openalex.org/W3035893083"],"related_works":["https://openalex.org/W2948841882","https://openalex.org/W2982278711","https://openalex.org/W3162849280","https://openalex.org/W3035893083","https://openalex.org/W2780791607","https://openalex.org/W3174768752","https://openalex.org/W2281767740","https://openalex.org/W3008284665","https://openalex.org/W2754466052","https://openalex.org/W2760421385"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Nivolumab,":[1],"a":[2,81,166,193],"programmed":[3],"death-1(PD-1)":[4],"inhibitor":[5],"antibody,":[6],"have":[7,243],"demonstrated":[8],"anti-tumor":[9],"activity":[10],"for":[11,130,138,234],"multiple":[12],"malignancies.":[13],"Such":[14],"immune":[15,65,91,118,219,245],"checkpoint":[16,220,246],"inhibitors":[17,247],"induce":[18],"novel":[19],"and":[20,148,171],"distinctive":[21],"adverse":[22,29,32,49,70,258],"effects,":[23],"which":[24,205],"are":[25],"collectively":[26],"named":[27],"immune-related":[28,48,69,181,210,257],"events.":[30,211],"Immune-related":[31],"events":[33,50,259],"can":[34],"theoretically":[35],"occur":[36],"at":[37],"any":[38],"part":[39],"of":[40,55,64,75,98,109,168,185,192,203,218,230,254],"the":[41,44,104,176,215],"body,":[42],"including":[43],"haemopoietic":[45],"system.":[46],"Most":[47,180],"developed":[51,72,90,182,224],"within":[52],"10":[53],"weeks":[54],"receiving":[56],"immunotherapy.":[57,76,186],"Thus":[58],"far,":[59],"there":[60],"is":[61,207,214],"no":[62],"report":[63,217],"thrombocytopenia":[66,92,101,119,222],"as":[67],"an":[68],"event":[71],"after":[73,96,201,228],"discontinuation":[74,97,202,229],"CASE":[77],"REPORT:":[78],"We":[79],"describe":[80],"62-year-old":[82],"male":[83],"with":[84,232],"metastatic":[85,235],"non-small":[86],"cell":[87],"lung":[88],"cancer":[89],"nearly":[93,225],"two":[94],"months":[95,184,198,227],"nivolumab.":[99],"When":[100],"was":[102,106,120],"detected,":[103],"patient":[105],"undergoing":[107],"radiotherapy":[108],"supraclavicular":[110],"lymph":[111],"nodes.":[112],"After":[113,158],"complex":[114],"diagnosis-by-exclusion":[115],"process,":[116],"nivolumab-induced":[117],"diagnosed.":[121],"MANAGEMENT":[122],"AND":[123],"OUTCOME:":[124],"Intravenous":[125],"immunoglobulins":[126],"20":[127],"g":[128],"daily":[129,137],"5":[131],"days,":[132,160],"intravenous":[133],"methylprednisolone":[134],"40":[135],"mg":[136,154],"14":[139],"days":[140],"followed":[141],"by":[142],"oral":[143,149],"prednisone,":[144],"intermittent":[145],"platelet":[146,162],"transfusion":[147],"thrombopoietin":[150],"receptor":[151],"(eltrombopag":[152],"25":[153],"daily)":[155],"were":[156],"administered.":[157],"30":[159],"his":[161],"count":[163],"had":[164],"achieved":[165],"level":[167],"adequate":[169],"hemostasis":[170],"continued":[172],"to":[173,189,199],"improvement":[174],"during":[175],"tapering":[177],"period.":[178],"DISCUSSION:":[179],"6":[183],"Clinicians":[187],"need":[188],"be":[190,261],"aware":[191],"clinical":[194,239],"diagnostic":[195],"complex,":[196],"developing":[197],"years":[200],"immunotherapy,":[204],"recently":[206],"termed":[208],"delayed":[209],"This":[212],"case":[213],"first":[216],"inhibitors-induced":[221],"that":[223],"2":[226],"treatment":[231],"nivolumab":[233],"NSCLC.":[236],"In":[237],"future":[238],"practice,":[240],"patients":[241],"who":[242],"received":[244],"develop":[248],"new":[249],"or":[250],"unexplained":[251],"symptom,":[252],"irrespective":[253],"interval":[255],"post-immunotherapy,":[256],"should":[260],"considered.":[262]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-01-18T00:00:00"}